 | • レポートコード：QYR2104Z5680 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、トポテカンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、カプセル）、用途別市場規模（小細胞肺がん、転移性進行卵巣がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・トポテカンの市場動向 ・企業の競争状況、市場シェア ・トポテカンの種類別市場規模（注射、カプセル） ・トポテカンの用途別市場規模（小細胞肺がん、転移性進行卵巣がん） ・トポテカンの北米市場規模2016-2027（アメリカ、カナダ） ・トポテカンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・トポテカンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・トポテカンの中南米市場規模2016-2027（メキシコ、ブラジル） ・トポテカンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ark Pharm、GSK、Jiangsu Aosaikang Pharmaceutical、Nanjing Ruinian Best Pharmaceutical、Guizhou Hanfang Pharmaceutical、Grand Pharmaceutical、Jiangsu Hengrui Pharmaceutical、Sichuan Keruide Kaihua Pharmaceutical、Yangtze Pharmaceutical Group） ・結論 |
Topotecan, a camptothecin semi-synthetic derivative, is a drug that inhibits topoisomerase and can bind topoisomerase DNA complex to prevent the relinking of broken DNA single strand.Formation of topology for kang – topoisomerase Ⅰ – ternary complexes and DNA replication enzyme interaction, the double-stranded DNA damage.Mammalian cells cannot efficiently repair damaged DNA double stranded.
Market Analysis and Insights: Global Topotecan Market
The global Topotecan market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Topotecan market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Topotecan market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Topotecan market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Topotecan market.
Global Topotecan Scope and Market Size
Topotecan market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Topotecan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Capsule
Segment by Application
Small Cell Lung Cancer
Metastatic Advanced Ovarian Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ark Pharm
GSK
Jiangsu Aosaikang Pharmaceutical
Nanjing Ruinian Best Pharmaceutical
Guizhou Hanfang Pharmaceutical
Grand Pharmaceutical
Jiangsu Hengrui Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Topotecan Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Topotecan Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Small Cell Lung Cancer
1.3.3 Metastatic Advanced Ovarian Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Topotecan Market Perspective (2016-2027)
2.2 Topotecan Growth Trends by Regions
2.2.1 Topotecan Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Topotecan Historic Market Share by Regions (2016-2021)
2.2.3 Topotecan Forecasted Market Size by Regions (2022-2027)
2.3 Topotecan Industry Dynamic
2.3.1 Topotecan Market Trends
2.3.2 Topotecan Market Drivers
2.3.3 Topotecan Market Challenges
2.3.4 Topotecan Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Topotecan Players by Revenue
3.1.1 Global Top Topotecan Players by Revenue (2016-2021)
3.1.2 Global Topotecan Revenue Market Share by Players (2016-2021)
3.2 Global Topotecan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Topotecan Revenue
3.4 Global Topotecan Market Concentration Ratio
3.4.1 Global Topotecan Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Topotecan Revenue in 2020
3.5 Topotecan Key Players Head office and Area Served
3.6 Key Players Topotecan Product Solution and Service
3.7 Date of Enter into Topotecan Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Topotecan Breakdown Data by Type
4.1 Global Topotecan Historic Market Size by Type (2016-2021)
4.2 Global Topotecan Forecasted Market Size by Type (2022-2027)
5 Topotecan Breakdown Data by Application
5.1 Global Topotecan Historic Market Size by Application (2016-2021)
5.2 Global Topotecan Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Topotecan Market Size (2016-2027)
6.2 North America Topotecan Market Size by Type
6.2.1 North America Topotecan Market Size by Type (2016-2021)
6.2.2 North America Topotecan Market Size by Type (2022-2027)
6.2.3 North America Topotecan Market Size by Type (2016-2027)
6.3 North America Topotecan Market Size by Application
6.3.1 North America Topotecan Market Size by Application (2016-2021)
6.3.2 North America Topotecan Market Size by Application (2022-2027)
6.3.3 North America Topotecan Market Size by Application (2016-2027)
6.4 North America Topotecan Market Size by Country
6.4.1 North America Topotecan Market Size by Country (2016-2021)
6.4.2 North America Topotecan Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Topotecan Market Size (2016-2027)
7.2 Europe Topotecan Market Size by Type
7.2.1 Europe Topotecan Market Size by Type (2016-2021)
7.2.2 Europe Topotecan Market Size by Type (2022-2027)
7.2.3 Europe Topotecan Market Size by Type (2016-2027)
7.3 Europe Topotecan Market Size by Application
7.3.1 Europe Topotecan Market Size by Application (2016-2021)
7.3.2 Europe Topotecan Market Size by Application (2022-2027)
7.3.3 Europe Topotecan Market Size by Application (2016-2027)
7.4 Europe Topotecan Market Size by Country
7.4.1 Europe Topotecan Market Size by Country (2016-2021)
7.4.2 Europe Topotecan Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Topotecan Market Size (2016-2027)
8.2 Asia-Pacific Topotecan Market Size by Type
8.2.1 Asia-Pacific Topotecan Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Topotecan Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Topotecan Market Size by Type (2016-2027)
8.3 Asia-Pacific Topotecan Market Size by Application
8.3.1 Asia-Pacific Topotecan Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Topotecan Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Topotecan Market Size by Application (2016-2027)
8.4 Asia-Pacific Topotecan Market Size by Region
8.4.1 Asia-Pacific Topotecan Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Topotecan Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Topotecan Market Size (2016-2027)
9.2 Latin America Topotecan Market Size by Type
9.2.1 Latin America Topotecan Market Size by Type (2016-2021)
9.2.2 Latin America Topotecan Market Size by Type (2022-2027)
9.2.3 Latin America Topotecan Market Size by Type (2016-2027)
9.3 Latin America Topotecan Market Size by Application
9.3.1 Latin America Topotecan Market Size by Application (2016-2021)
9.3.2 Latin America Topotecan Market Size by Application (2022-2027)
9.3.3 Latin America Topotecan Market Size by Application (2016-2027)
9.4 Latin America Topotecan Market Size by Country
9.4.1 Latin America Topotecan Market Size by Country (2016-2021)
9.4.2 Latin America Topotecan Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Topotecan Market Size (2016-2027)
10.2 Middle East & Africa Topotecan Market Size by Type
10.2.1 Middle East & Africa Topotecan Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Topotecan Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Topotecan Market Size by Type (2016-2027)
10.3 Middle East & Africa Topotecan Market Size by Application
10.3.1 Middle East & Africa Topotecan Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Topotecan Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Topotecan Market Size by Application (2016-2027)
10.4 Middle East & Africa Topotecan Market Size by Country
10.4.1 Middle East & Africa Topotecan Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Topotecan Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ark Pharm
11.1.1 Ark Pharm Company Details
11.1.2 Ark Pharm Business Overview
11.1.3 Ark Pharm Topotecan Introduction
11.1.4 Ark Pharm Revenue in Topotecan Business (2016-2021)
11.1.5 Ark Pharm Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Topotecan Introduction
11.2.4 GSK Revenue in Topotecan Business (2016-2021)
11.2.5 GSK Recent Development
11.3 Jiangsu Aosaikang Pharmaceutical
11.3.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.3.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.3.3 Jiangsu Aosaikang Pharmaceutical Topotecan Introduction
11.3.4 Jiangsu Aosaikang Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.3.5 Jiangsu Aosaikang Pharmaceutical Recent Development
11.4 Nanjing Ruinian Best Pharmaceutical
11.4.1 Nanjing Ruinian Best Pharmaceutical Company Details
11.4.2 Nanjing Ruinian Best Pharmaceutical Business Overview
11.4.3 Nanjing Ruinian Best Pharmaceutical Topotecan Introduction
11.4.4 Nanjing Ruinian Best Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.4.5 Nanjing Ruinian Best Pharmaceutical Recent Development
11.5 Guizhou Hanfang Pharmaceutical
11.5.1 Guizhou Hanfang Pharmaceutical Company Details
11.5.2 Guizhou Hanfang Pharmaceutical Business Overview
11.5.3 Guizhou Hanfang Pharmaceutical Topotecan Introduction
11.5.4 Guizhou Hanfang Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.5.5 Guizhou Hanfang Pharmaceutical Recent Development
11.6 Grand Pharmaceutical
11.6.1 Grand Pharmaceutical Company Details
11.6.2 Grand Pharmaceutical Business Overview
11.6.3 Grand Pharmaceutical Topotecan Introduction
11.6.4 Grand Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.6.5 Grand Pharmaceutical Recent Development
11.7 Jiangsu Hengrui Pharmaceutical
11.7.1 Jiangsu Hengrui Pharmaceutical Company Details
11.7.2 Jiangsu Hengrui Pharmaceutical Business Overview
11.7.3 Jiangsu Hengrui Pharmaceutical Topotecan Introduction
11.7.4 Jiangsu Hengrui Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.7.5 Jiangsu Hengrui Pharmaceutical Recent Development
11.8 Sichuan Keruide Kaihua Pharmaceutical
11.8.1 Sichuan Keruide Kaihua Pharmaceutical Company Details
11.8.2 Sichuan Keruide Kaihua Pharmaceutical Business Overview
11.8.3 Sichuan Keruide Kaihua Pharmaceutical Topotecan Introduction
11.8.4 Sichuan Keruide Kaihua Pharmaceutical Revenue in Topotecan Business (2016-2021)
11.8.5 Sichuan Keruide Kaihua Pharmaceutical Recent Development
11.9 Yangtze Pharmaceutical Group
11.9.1 Yangtze Pharmaceutical Group Company Details
11.9.2 Yangtze Pharmaceutical Group Business Overview
11.9.3 Yangtze Pharmaceutical Group Topotecan Introduction
11.9.4 Yangtze Pharmaceutical Group Revenue in Topotecan Business (2016-2021)
11.9.5 Yangtze Pharmaceutical Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Topotecan Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Capsule
Table 4. Global Topotecan Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Topotecan Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Topotecan Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Topotecan Market Share by Regions (2016-2021)
Table 8. Global Topotecan Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Topotecan Market Share by Regions (2022-2027)
Table 10. Topotecan Market Trends
Table 11. Topotecan Market Drivers
Table 12. Topotecan Market Challenges
Table 13. Topotecan Market Restraints
Table 14. Global Topotecan Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Topotecan Market Share by Players (2016-2021)
Table 16. Global Top Topotecan Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Topotecan as of 2020)
Table 17. Ranking of Global Top Topotecan Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Topotecan Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Topotecan Product Solution and Service
Table 21. Date of Enter into Topotecan Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Topotecan Revenue Market Share by Type (2016-2021)
Table 25. Global Topotecan Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Topotecan Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Topotecan Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Topotecan Revenue Market Share by Application (2016-2021)
Table 29. Global Topotecan Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Topotecan Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Topotecan Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Topotecan Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Topotecan Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Topotecan Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Topotecan Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Topotecan Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Topotecan Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Topotecan Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Topotecan Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Topotecan Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Topotecan Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Topotecan Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Topotecan Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Topotecan Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Topotecan Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Topotecan Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Topotecan Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Topotecan Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Topotecan Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Topotecan Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Topotecan Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Topotecan Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Topotecan Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Topotecan Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Topotecan Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Topotecan Market Size by Country (2022-2027) & (US$ Million)
Table 61. Ark Pharm Company Details
Table 62. Ark Pharm Business Overview
Table 63. Ark Pharm Topotecan Product
Table 64. Ark Pharm Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 65. Ark Pharm Recent Development
Table 66. GSK Company Details
Table 67. GSK Business Overview
Table 68. GSK Topotecan Product
Table 69. GSK Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 70. GSK Recent Development
Table 71. Jiangsu Aosaikang Pharmaceutical Company Details
Table 72. Jiangsu Aosaikang Pharmaceutical Business Overview
Table 73. Jiangsu Aosaikang Pharmaceutical Topotecan Product
Table 74. Jiangsu Aosaikang Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 75. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 76. Nanjing Ruinian Best Pharmaceutical Company Details
Table 77. Nanjing Ruinian Best Pharmaceutical Business Overview
Table 78. Nanjing Ruinian Best Pharmaceutical Topotecan Product
Table 79. Nanjing Ruinian Best Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 80. Nanjing Ruinian Best Pharmaceutical Recent Development
Table 81. Guizhou Hanfang Pharmaceutical Company Details
Table 82. Guizhou Hanfang Pharmaceutical Business Overview
Table 83. Guizhou Hanfang Pharmaceutical Topotecan Product
Table 84. Guizhou Hanfang Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 85. Guizhou Hanfang Pharmaceutical Recent Development
Table 86. Grand Pharmaceutical Company Details
Table 87. Grand Pharmaceutical Business Overview
Table 88. Grand Pharmaceutical Topotecan Product
Table 89. Grand Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 90. Grand Pharmaceutical Recent Development
Table 91. Jiangsu Hengrui Pharmaceutical Company Details
Table 92. Jiangsu Hengrui Pharmaceutical Business Overview
Table 93. Jiangsu Hengrui Pharmaceutical Topotecan Product
Table 94. Jiangsu Hengrui Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 95. Jiangsu Hengrui Pharmaceutical Recent Development
Table 96. Sichuan Keruide Kaihua Pharmaceutical Company Details
Table 97. Sichuan Keruide Kaihua Pharmaceutical Business Overview
Table 98. Sichuan Keruide Kaihua Pharmaceutical Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 99. Sichuan Keruide Kaihua Pharmaceutical Recent Development
Table 100. Yangtze Pharmaceutical Group Company Details
Table 101. Yangtze Pharmaceutical Group Business Overview
Table 102. Yangtze Pharmaceutical Group Topotecan Product
Table 103. Yangtze Pharmaceutical Group Revenue in Topotecan Business (2016-2021) & (US$ Million)
Table 104. Yangtze Pharmaceutical Group Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Topotecan Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Capsule Features
Figure 4. Global Topotecan Market Share by Application: 2020 VS 2027
Figure 5. Small Cell Lung Cancer Case Studies
Figure 6. Metastatic Advanced Ovarian Cancer Case Studies
Figure 7. Topotecan Report Years Considered
Figure 8. Global Topotecan Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Topotecan Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Topotecan Market Share by Regions: 2020 VS 2027
Figure 11. Global Topotecan Market Share by Regions (2022-2027)
Figure 12. Global Topotecan Market Share by Players in 2020
Figure 13. Global Top Topotecan Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Topotecan as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Topotecan Revenue in 2020
Figure 15. Global Topotecan Revenue Market Share by Type (2016-2021)
Figure 16. Global Topotecan Revenue Market Share by Type (2022-2027)
Figure 17. North America Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Topotecan Market Share by Type (2016-2027)
Figure 19. North America Topotecan Market Share by Application (2016-2027)
Figure 20. North America Topotecan Market Share by Country (2016-2027)
Figure 21. United States Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Topotecan Market Share by Type (2016-2027)
Figure 25. Europe Topotecan Market Share by Application (2016-2027)
Figure 26. Europe Topotecan Market Share by Country (2016-2027)
Figure 27. Germany Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Topotecan Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Topotecan Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Topotecan Market Share by Region (2016-2027)
Figure 37. China Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Topotecan Market Share by Type (2016-2027)
Figure 45. Latin America Topotecan Market Share by Application (2016-2027)
Figure 46. Latin America Topotecan Market Share by Country (2016-2027)
Figure 47. Mexico Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Topotecan Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Topotecan Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Topotecan Market Share by Country (2016-2027)
Figure 53. Turkey Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Topotecan Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Ark Pharm Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 57. GSK Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 58. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 59. Nanjing Ruinian Best Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 60. Guizhou Hanfang Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 61. Grand Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 62. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 63. Sichuan Keruide Kaihua Pharmaceutical Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 64. Yangtze Pharmaceutical Group Revenue Growth Rate in Topotecan Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のトポテカン市場規模・現状・予測（2021年-2027年） Topotecan, a camptothecin semi-synthetic derivative, is a drug that inhibits topoisomerase and can bind topoisomerase DNA complex to prevent the relinking of broken DNA single strand.Formation of topology for kang - topoisomerase Ⅰ - ternary complexes and DNA replication enzyme interaction, the doub…- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…